Search results for ' Delta Delta Delta'

Govt subsidies have forced US airlines out of India: Delta CEO

Govt subsidies have forced US airlines out of India: Delta CEO

Rediff.com19 May 2015

A long-haul 777 in the US drives about almost 1,000 jobs per flight.

Maharashtra allows schools to reopen offline from Jan 24

Maharashtra allows schools to reopen offline from Jan 24

Rediff.com21 Jan 2022

Maharashtra minister Varsha Gaikwad on Thursday said that schools for Classes 1 to 9 in the state can be reopened for offline classroom sessions from January 24.

Kerala imposes fresh curbs as Covid cases see massive surge

Kerala imposes fresh curbs as Covid cases see massive surge

Rediff.com20 Jan 2022

The Kerala government imposed fresh restrictions in the state as a preventive measure to contain the rising number of COVID-19 cases.

5G scare: Air India cancels 14 US flights

5G scare: Air India cancels 14 US flights

Rediff.com19 Jan 2022

Air India cancelled 14 flights on India-US routes from Wednesday onwards due to deployment of 5G internet in North America which could interfere with aircraft's navigation systems. Meanwhile, DGCA chief Arun Kumar told PTI that the Indian aviation regulator was working "in close coordination with our carriers to overcome the situation" that has arisen due to 5G internet's deployment in the US. US aviation regulator Federal Aviation Administration (FAA) had on January 14 said that "5G interference with the aircraft's radio altimeter could prevent engine and braking systems from transitioning to landing mode, which could prevent an aircraft from stopping on the runway".

UN warns of 'similar episodes' as second Covid wave in India

UN warns of 'similar episodes' as second Covid wave in India

Rediff.com13 Jan 2022

'In India, a deadly wave of infection with the Delta variant stole 240,000 lives between April and June and disrupted economic recovery. Similar episodes could take place in the near term,' said the report.

Preliminary data shows Vaxzevria booster works against Omicron: AstraZeneca

Preliminary data shows Vaxzevria booster works against Omicron: AstraZeneca

Rediff.com13 Jan 2022

The study also noted that the booster dosage of the company's COVID-19 vaccine Vaxzevria also increased the immune response to Beta, Delta, Alpha and Gamma SARS-CoV-2 variants.

Omicron's explosive, threat level very high globally: INSACOG

Omicron's explosive, threat level very high globally: INSACOG

Rediff.com10 Jan 2022

In its weekly bulletin of December 27, released on Monday, the Indian SARS-CoV-2 Genomics Consortium (INSACOG) said global outbreaks of SARS-CoV-2 are increasingly shifting from Delta to Omicron.

Low Covid hopitalisation rate may change quickly: Govt

Low Covid hopitalisation rate may change quickly: Govt

Rediff.com10 Jan 2022

Five to 10 per cent of the active Covid cases this time so far needed hospitalisation but the situation is dynamic and may change rapidly, the Centre said on Monday and asked states to keep a watch on cases under home isolation and in hospitals.

TN observes one-day shutdown to help tackle surging Covid cases

TN observes one-day shutdown to help tackle surging Covid cases

Rediff.com9 Jan 2022

A one-day complete lockdown to tackle the rapidly rising COVID-19 cases was enforced across Tamil Nadu on Sunday while police, local and health authorities stepped up measures to check violations.

A big challenge to EPFO returns

A big challenge to EPFO returns

Rediff.com18 Mar 2022

There is widening gap between what the government's premier retirement fund makes on its investments and what it offers to employees. The Employees' Provident Fund Organisation (EPFO) makes the bulk of its investments in government-related securities. In other words, it lends to central and state governments and related entities. The interest it gets from these instruments is largely what it uses to pay interest to its subscribers.

Nizamuddin Markaz reopens for two days for Shab-e-Barat prayers

Nizamuddin Markaz reopens for two days for Shab-e-Barat prayers

Rediff.com17 Mar 2022

According to the police, the doors of the markaz were opened at around 12.30 pm.

For first time after March 2020, Delhi's LNJP hospital has 0 Covid cases

For first time after March 2020, Delhi's LNJP hospital has 0 Covid cases

Rediff.com17 Mar 2022

The Delhi government-run LNJP Hospital, the mainstay of the city's fight against the Covid-19 pandemic, now has "zero patient" admitted at the facility, the first time since March 2020, Health Minister Satyendar Jain said on Thursday.

Mumbai's Covid cases may peak between Jan 6-13, says TIFR scientist

Mumbai's Covid cases may peak between Jan 6-13, says TIFR scientist

Rediff.com5 Jan 2022

As coronavirus infections surged in Mumbai, the city could witness a peak between January 6 to 13 and take a month for the cases to see a decline, according to researchers at the Tata Institute of Fundamental Research.

Covaxin, Covishield mix and match 4 times as effective: Study

Covaxin, Covishield mix and match 4 times as effective: Study

Rediff.com4 Jan 2022

The most important finding of the study was that the Spike-protein neutralising antibodies found in the mixed vaccine groups were significantly higher than the same-vaccine groups, D Nageshwar Reddy, Chairman of AIG Hospitals said.

Third jab can give 88% protection against Omicron: UK studies

Third jab can give 88% protection against Omicron: UK studies

Rediff.com3 Jan 2022

A third dose of COVID-19 vaccine can provide up to 88 per cent protection against hospitalisation from infection by the Omicron variant of coronavirus, according to early results from studies conducted in the UK.

Yogi says Omicron 'common viral fever', but caution important

Yogi says Omicron 'common viral fever', but caution important

Rediff.com3 Jan 2022

He said it took 15-25 days to recover for those who were infected with the Delta variant of the virus in March-April last year and even after recuperating, they complained about a number of problems.

China's 'zero case' policy under stress due to spike in Covid cases

China's 'zero case' policy under stress due to spike in Covid cases

Rediff.com30 Dec 2021

China's Zero-COVID-19 case policy is increasingly coming under stress as the country is reporting a spike in the number of coronavirus infections from different provinces ahead of the Beijing Winter Olympic Games with over 2,500 people undergoing treatment.

Omicron causing 'tsunami' of Covid cases: WHO chief

Omicron causing 'tsunami' of Covid cases: WHO chief

Rediff.com30 Dec 2021

The WHO chief warned that it will continue to put immense pressure on exhausted health workers and health systems on the brink of collapse and again disturbing lives and livelihoods.

Omicron has high potential of evading immune system: INSACOG

Omicron has high potential of evading immune system: INSACOG

Rediff.com29 Dec 2021

The genomic consortium, citing global data, said there is now clear experimental and clinical data supporting very high immune escape potential of Omicron, which appears to be the major component of its growth advantage over Delta.

Omicron risk remains 'very high', says WHO

Omicron risk remains 'very high', says WHO

Rediff.com29 Dec 2021

The weekly epidemiological update by WHO revealed the week of December 20-26 saw the global number of new COVID-19 cases increase by 11 per cent as compared to the previous week.

Biological E plans to make 100m Corbevax jabs per month from Feb 2022

Biological E plans to make 100m Corbevax jabs per month from Feb 2022

Rediff.com28 Dec 2021

Biological E Limited plans to complete production at a rate of 75 million doses of its COVID-19 vaccine Corbevax per month, anticipating over 100 million doses per month from February 2022 which will enable the Hyderabad-based company to deliver 300 Million doses as promised to the Centre, BE said on Tuesday.

Third Covid wave in India may peak in early Feb: IIT-Kanpur study

Third Covid wave in India may peak in early Feb: IIT-Kanpur study

Rediff.com24 Dec 2021

The third wave of the COVID-19 pandemic in India may peak by February 3, 2022, claims a modelling study by researchers at Indian Institute of Technology Kanpur.

World witnessing 4th Covid surge, India must be on guard: Centre

World witnessing 4th Covid surge, India must be on guard: Centre

Rediff.com24 Dec 2021

The world is witnessing the fourth surge of the COVID-19 pandemic and India has to be on guard and cannot afford to slacken, said Union health secretary Rajesh Bhushan on Friday.

Sensex jumps 385 points on firm global cues

Sensex jumps 385 points on firm global cues

Rediff.com23 Dec 2021

PowerGrid was the top gainer in the Sensex pack, rising around 4 per cent, followed by ITC, Bajaj Finance, Infosys, NTPC and Tech Mahindra. NSE Nifty advanced 117.15 points to 17,072.60.

Vaccine-generated antibodies no shield against Omicron, says study, booster a must

Vaccine-generated antibodies no shield against Omicron, says study, booster a must

Rediff.com2 Mar 2022

Antibodies produced by two doses of mRNA vaccines against the original and early variants of the SARS-CoV-2 virus wane substantially over time, and offer essentially no protection against Omicron, according to a study that highlights the importance of a booster dose.

UK logs 93,045 new Covid cases amid surge in Omicron infections

UK logs 93,045 new Covid cases amid surge in Omicron infections

Rediff.com18 Dec 2021

The UK reported 93,045 cases of coronavirus on Friday, another record high for daily infections for the third consecutive day, as Omicron overtook Delta to become the dominant variant in London and Scotland.

Covid cases are being detected by accident

Covid cases are being detected by accident

Rediff.com30 Apr 2022

'A patient visits for any other treatment, but a routine Covid test finds him to be positive.' 'Not only are they, but their whole family is also coming out to be positive.'

Higher Omicron infection risk despite full vax: Study

Higher Omicron infection risk despite full vax: Study

Rediff.com14 Dec 2021

Two doses of Pfizer and AstraZeneca COVID-19 vaccines generate lower levels of antibodies against the Omicron variant of coronavirus, according to a study which suggests that those previously infected or vaccinated may be at an increased risk of infection.

TN chariot tragedy: It was all over in a matter of minutes, says witness

TN chariot tragedy: It was all over in a matter of minutes, says witness

Rediff.com27 Apr 2022

Villagers say that the wooden temple chariot, with parts being iron based fitment, was decorated with colourful lights especially on the top, and it came into contact with the overhead electricity line.

UK opens up COVID boosters to all over 30s in Omicron fight

UK opens up COVID boosters to all over 30s in Omicron fight

Rediff.com12 Dec 2021

There are around 7.5 million people aged 30 to 39, and 3.5 million of those are eligible for boosters from Monday, NHS England said.

Beijing begins 3-time Covid testing of 3.5 mm people as 51 die in Shanghai

Beijing begins 3-time Covid testing of 3.5 mm people as 51 die in Shanghai

Rediff.com25 Apr 2022

Beijing's health officials on Monday announced 29 fresh cases taking the total cases to 70 in the city.

Sensex overcomes Omicron fear; surges 1,016 points at close

Sensex overcomes Omicron fear; surges 1,016 points at close

Rediff.com8 Dec 2021

Bajaj Finance was the top gainer in the Sensex pack, rising around 4 per cent, followed by Maruti, SBI, Bajaj Finserv, Sun Pharma and Asian Paints. NSE Nifty rallied 293.05 points to 17,469.75.

Sensex soars 887 pts on global market rebound

Sensex soars 887 pts on global market rebound

Rediff.com7 Dec 2021

Recovering from a two-session carnage, equity benchmark Sensex rebounded 887 points on Tuesday, led by gains in index majors ICICI Bank, HDFC twins and Infosys amid a positive trend in global markets. According to experts, global equity markets are slightly relieved after studies pertaining to the Omicron strain of COVID-19 suggest that even though it is fast spreading, it is largely milder than the Delta variant. The 30-share BSE Sensex ended 886.51 points or 1.56 per cent higher at 57,633.65.

Omicron: 'Vaccine immunity may be less effective'

Omicron: 'Vaccine immunity may be less effective'

Rediff.com7 Dec 2021

'Antiviral treatment will have no change. Spike protein change may affect the immunity protection.'

With Omicron, 3rd wave projected to hit India by Feb

With Omicron, 3rd wave projected to hit India by Feb

Rediff.com6 Dec 2021

With Omicron, the new variant of SARS-CoV2, the third wave of coronavirus could hit the peak by February with cases likely to be reaching up to 1-1.5 lakh a day in the country, but it will be milder than the second wave, Manindra Agarwal, IIT scientist involved in the mathematical projection of trajectory of COVID-19, said.

When will Covid end? Here's what experts say

When will Covid end? Here's what experts say

Rediff.com15 Feb 2022

'Unless we see four weeks of low and stable numbers with only minor fluctuations, we cannot call the valley as endemic just as yet'

In Mumbai, Omicron found in 95% of samples in latest genome sequencing

In Mumbai, Omicron found in 95% of samples in latest genome sequencing

Rediff.com15 Feb 2022

Out of the total 190 samples, 180 (94.74 per cent) were found infected with Omicron, three with the Delta variant (1.58 per cent), one with Delta (0.53 per cent) and six with other strains of coronavirus (3.16 per cent), a Brihanmumbai Municipal Corporation (BMC) release said, citing test results of the ninth round of genome sequencing in the city.

Omicron has been around for some time, says SA doctor who raised alarm

Omicron has been around for some time, says SA doctor who raised alarm

Rediff.com3 Dec 2021

Omicron very different from Delta, Beta COVID variants, says South African doctor Angelique Coetzee.

Covid SOPs to be decided with Centre: Ajit Pawar

Covid SOPs to be decided with Centre: Ajit Pawar

Rediff.com2 Dec 2021

Maharashtra Deputy Chief Minister Ajit Pawar on Thursday said future decisions on COVID-19 SOPs will be taken in consultation with the Union Health Ministry and the state Task Force, amid a difference between the Centre and the state over guidelines for international travellers in the wake of the new variant of SARS-CoV2.

Omicron variant jab could be ready in 100 days: Pfizer

Omicron variant jab could be ready in 100 days: Pfizer

Rediff.com2 Dec 2021

Pfizer's chief executive Dr Albert Bourla told the BBC that he is of the view that annual vaccinations would be needed to maintain a "very high level of protection" against the deadly disease that has claimed over five million lives across the world.